What is dicerna? Dicerna TM Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases.Why did dicerna pharmaceuticals drna stock fall 28 last week? For disappointed investors of Dicerna Pharmaceuticals (DRNA), the latter case sent the stock tumbling by 28% in a single session last week. Specifically, the downturn came about after the company released data from the phase 2 trial evaluating nedosiran as a treatment forWhen will dicerna release its second quarter 2021 financial results? LEXINGTON, Mass., August 02, 2021--Dicerna announced that the Company will release its second quarter 2021 financial results before market open on Monday, Aug. 9, 2021.Will dicerna submit a new drug application for hyperoxaluria to the fda? Dicerna Pharma in the fourth quarter expects to submit to the FDA a new-drug application for a treatment for hyperoxaluria, a genetic disorder. LEXINGTON, Mass., August 05, 2021--Dicerna announced positive top-line results from its PHYOX™2 pivotal clinical trial of nedosiran, which is in development for as a treatment for PH.